US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
ZA836080B
(en)
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
US4693981A
(en)
|
1983-12-20 |
1987-09-15 |
Advanced Genetics Research Institute |
Preparation of inactivated viral vaccines
|
US5106619A
(en)
|
1983-12-20 |
1992-04-21 |
Diamond Scientific Co. |
Preparation of inactivated viral vaccines
|
FR2583429B1
(fr)
|
1985-06-18 |
1989-11-03 |
Transgene Sa |
Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
DK0546073T3
(da)
|
1990-08-29 |
1998-02-02 |
Genpharm Int |
Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
|
US5484719A
(en)
|
1991-08-26 |
1996-01-16 |
Edible Vaccines, Inc. |
Vaccines produced and administered through edible plants
|
US6034298A
(en)
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
US5612487A
(en)
|
1991-08-26 |
1997-03-18 |
Edible Vaccines, Inc. |
Anti-viral vaccines expressed in plants
|
WO1993011236A1
(en)
|
1991-12-02 |
1993-06-10 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
WO1994016109A1
(en)
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
WO1994017826A1
(en)
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
US5573916A
(en)
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
EP1394259A3
(en)
|
1994-07-18 |
2004-04-14 |
Karl-Klaus Prof. Dr. Conzelmann |
Recombinant infectious non-segmented negative strand RNA virus
|
AU712714B2
(en)
|
1994-10-03 |
1999-11-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule B7 gene in a recombinant virus expressing system
|
DE69637481T2
(de)
|
1995-04-27 |
2009-04-09 |
Amgen Fremont Inc. |
Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
|
AU2466895A
(en)
|
1995-04-28 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
DE69510207T3
(de)
|
1995-08-09 |
2007-02-15 |
Schweiz. Serum- & Impfinstitut Bern |
Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
|
EP0865499B1
(en)
|
1995-09-14 |
2009-03-18 |
Virginia Tech Intellectual Properties, Inc. |
Production of lysosomal enzymes in plant-based expression systems
|
WO1997012032A1
(en)
|
1995-09-27 |
1997-04-03 |
The Government Of The United States Of America, As Represented By The Department Of Health And Human Services |
Production of infectious respiratory syncytial virus from cloned nucleotide sequences
|
JP2820106B2
(ja)
|
1996-02-29 |
1998-11-05 |
日本電気株式会社 |
トラヒックシェーパ装置
|
DE69736226T2
(de)
|
1996-04-19 |
2006-11-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Verfahren zur anregung einer immunantwort durch verabreichung von nutzorganismen, die intimin allein oder als fusionsprotein mit einem oder mehreren anderen antigenen exprimieren
|
WO1997040161A1
(en)
|
1996-04-19 |
1997-10-30 |
Henry M. Jackson Foundation For The Advancement Of Military Medecine |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
|
KR100894670B1
(ko)
|
1996-07-15 |
2009-04-22 |
더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 |
클론닝된 뉴클레오타이드 서열로부터 약독화된 호흡기 세포융합 바이러스 백신의 생산
|
US20050032211A1
(en)
|
1996-09-26 |
2005-02-10 |
Metabogal Ltd. |
Cell/tissue culturing device, system and method
|
IL155588A0
(en)
|
2003-04-27 |
2003-11-23 |
Metabogal Ltd |
Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
|
CN1232504A
(zh)
|
1996-09-27 |
1999-10-20 |
美国氰胺公司 |
在单链负义病毒目病毒内引起减毒的3'基因组启动子区和聚合酶基因中的突变
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
ATE387495T1
(de)
|
1996-12-03 |
2008-03-15 |
Amgen Fremont Inc |
Vollkommen humane antikörper die egfr binden
|
US5891705A
(en)
|
1997-04-08 |
1999-04-06 |
Pentose Pharmaceuticals, Inc. |
Method for inactivating a virus
|
TR199902553T2
(xx)
|
1997-04-14 |
2000-03-21 |
Micromet Gesellschaft F�R Biomedizinische Forschung Mbh |
�nsan v�cuduna kar�� antijen resept�rlerinin �retimi i�in yeni metod ve kullan�mlar�.
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
KR100702523B1
(ko)
|
1997-05-23 |
2007-04-04 |
더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 |
클로닝된 뉴클레오타이드 서열로부터 약독화된파라인플루엔자 바이러스를 제조하는 방법
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
PT1012244E
(pt)
|
1997-07-11 |
2007-08-21 |
Univ Yale |
''rabdovírus com revestimentos remanipulados''
|
KR20010030630A
(ko)
|
1997-09-19 |
2001-04-16 |
윌리암 에이취 캘넌, 에곤 이 버그 |
약독화 호흡 신시티아 바이러스
|
KR20060080249A
(ko)
|
1998-06-12 |
2006-07-07 |
마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 |
변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스
|
CA2334857C
(en)
|
1998-06-12 |
2012-03-20 |
Mount Sinai School Of Medicine Of The City University Of New York |
Interferon inducing genetically engineered attenuated viruses
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
EP1230257A4
(en)
|
1998-12-23 |
2003-08-13 |
Thompson Boyce Plant Res |
EXPRESSION OF IMMUNOGENOUS HEPATITIS B SURFACE ANTIGEN IN TRANSGENIC PLANTS
|
AT407958B
(de)
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
IL146062A0
(en)
|
1999-04-29 |
2002-07-25 |
Marlow Foods Ltd |
Herbicide resistant plants
|
DK1194580T4
(da)
|
1999-07-14 |
2011-01-03 |
Sinai School Medicine |
In-vitro rekonstitution af segmenterede negativstrengede RNA-virus
|
CA2383105C
(en)
|
1999-09-24 |
2010-01-26 |
Smithkline Beecham Biologicals S.A. |
Intranasal influenza virus vaccine
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
WO2001071014A2
(en)
|
2000-03-17 |
2001-09-27 |
Boyce Thompson Institute For Plant Research, Inc. |
Expression of recombinant human acetylcholinesterase in transgenic plants
|
US6951754B2
(en)
|
2000-04-28 |
2005-10-04 |
St. Jude Children's Research Hospital |
DNA transfection system for the generation of infectious influenza virus
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
IL153290A0
(en)
*
|
2000-06-23 |
2003-07-06 |
American Cyanamid Co |
Assembly of wild-type and chimeric influenza virus-like particles (vlps)
|
ES2563402T3
(es)
|
2002-02-13 |
2016-03-15 |
Wisconsin Alumni Research Foundation |
Señal para el empaquetamiento de vectores del virus de la gripe
|
WO2007095318A2
(en)
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
CA2514177A1
(en)
|
2003-01-29 |
2004-08-12 |
Josef Michl |
Tolerance-induced targeted antibody production
|
EP1594536B1
(en)
|
2003-01-30 |
2009-03-25 |
Novartis Vaccines and Diagnostics, Inc. |
Adjuvanted influenza vaccine
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
JP4368594B2
(ja)
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
US7951557B2
(en)
|
2003-04-27 |
2011-05-31 |
Protalix Ltd. |
Human lysosomal proteins from plant cell culture
|
AU2004235813B2
(en)
|
2003-05-05 |
2010-07-29 |
Boyce Thompson Institute For Plant Research |
Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
US8551756B2
(en)
|
2003-07-11 |
2013-10-08 |
Novavax, Inc. |
Avian influenza chimeric VLPS
|
ES2392891T3
(es)
|
2003-11-04 |
2012-12-14 |
The Administrators Of The Tulane Educational Fund |
Procedimiento de prevención de la fusión virus célula inhibiendo la función de la región de iniciación de fusión de virus de ARN que tienen proteínas de envoltura fusogénicas de membrana de clase I
|
EP1771552B1
(en)
|
2004-05-25 |
2012-08-01 |
MedImmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
KR20070085291A
(ko)
|
2004-10-13 |
2007-08-27 |
프로탈릭스 리미티드 |
식물 세포 배양에서 항체를 생산하는 시스템 및 방법
|
WO2006104615A2
(en)
|
2005-02-24 |
2006-10-05 |
University Of Massachusetts |
Influenza nucleic acids, polypeptides, and uses thereof
|
EP2963118B1
(en)
|
2005-06-01 |
2017-08-09 |
California Institute of Technology |
Method of targeted gene delivery using viral vectors
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
KR20070000554A
(ko)
|
2005-06-27 |
2007-01-03 |
삼성전자주식회사 |
이종 망에서 복합 서비스를 위한 자원 관리방법
|
PE20070171A1
(es)
|
2005-06-30 |
2007-03-08 |
Boehringer Ingelheim Int |
GLICINAMIDAS SUSTITUIDAS CON EFECTO ANTITROMBOTICO E INHIBIDOR DEL FACTOR Xa
|
US7951384B2
(en)
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
ES2377884T3
(es)
|
2005-11-04 |
2012-04-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
|
PT2529747T
(pt)
|
2005-12-02 |
2018-05-09 |
Icahn School Med Mount Sinai |
Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações
|
US7914797B2
(en)
|
2005-12-06 |
2011-03-29 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Influenza vaccine
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
US20070207171A1
(en)
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
TW200745158A
(en)
|
2006-03-07 |
2007-12-16 |
Vaxinnate Corp |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
ES2376492T3
(es)
|
2006-03-23 |
2012-03-14 |
Novartis Ag |
Compuestos de imidazoquinoxalina como inmunomoduladores.
|
CA2646891A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
CA2646349A1
(en)
|
2006-03-24 |
2007-10-04 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Storage of influenza vaccines without refrigeration
|
US9101578B2
(en)
|
2006-05-01 |
2015-08-11 |
Technovax, Inc. |
Polyvalent influenza virus-like particle (VLP) compositions
|
US20070262178A1
(en)
|
2006-05-12 |
2007-11-15 |
Ultradent Products, Inc. |
Syringe delivery tip including an enlarged flocked wing element adjacent a distal delivery end
|
US20080014205A1
(en)
|
2006-05-15 |
2008-01-17 |
Lawrence Horowitz |
Neutralizing Antibodies to Influenza Viruses
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
AU2007314550A1
(en)
|
2006-05-18 |
2008-05-08 |
Pharmexa Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
JP2009542313A
(ja)
|
2006-06-27 |
2009-12-03 |
アドビオ・アクチボラゲット |
骨表面の術中局所薬物処置のための薬物送達デバイス、キット及び方法
|
EP2035565A4
(en)
|
2006-06-30 |
2010-07-21 |
Novavax Inc |
METHODS OF ENHANCING THE INCORPORATION OF PROTEINS IN VIRUS-LIKE PARTICLES (VLPs)
|
EP2526774A3
(en)
|
2006-07-21 |
2013-03-06 |
California Institute of Technology |
Targeted gene delivery for dendritic cell vaccination
|
EA017203B1
(ru)
|
2006-09-07 |
2012-10-30 |
Круселл Холланд Б.В. |
Связывающие молекулы человека, способные нейтрализовать вирус гриппа h5n1, и их применение
|
ES2694805T7
(es)
|
2006-09-11 |
2021-10-21 |
Seqirus Uk Ltd |
Fabricación de vacunas contra virus de la gripe sin usar huevos
|
EP2716656B1
(en)
|
2007-06-15 |
2016-10-12 |
Xiamen University |
Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
|
EP2014279A1
(en)
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
EP2185191B1
(en)
|
2007-06-27 |
2012-09-12 |
Novartis AG |
Low-additive influenza vaccines
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
PL2540312T3
(pl)
|
2007-07-19 |
2015-10-30 |
Novavax Inc |
Chimeryczne VLP ptasiej grypy
|
US20090092635A1
(en)
|
2007-08-17 |
2009-04-09 |
Wyeth |
Heterologous prime-boost immunization regimen
|
WO2009088401A2
(en)
|
2007-09-24 |
2009-07-16 |
Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Immunostimulatory combinations of tlr ligands and methods of use
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
PT2610345E
(pt)
|
2007-11-27 |
2016-01-11 |
Medicago Inc |
Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
|
KR20100115346A
(ko)
|
2007-12-06 |
2010-10-27 |
다나-파버 캔서 인스티튜트 인크. |
인플루엔자 바이러스에 대한 항체 및 그의 이용 방법
|
WO2009092038A1
(en)
|
2008-01-16 |
2009-07-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Influenza dna vaccination and methods of use thereof
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
CA2719201A1
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc. |
Neutralizing molecules to viral antigens
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
EP2310409A2
(en)
|
2008-06-17 |
2011-04-20 |
Apogenix GmbH |
Multimeric tnf receptors
|
CN102203252B
(zh)
|
2008-06-25 |
2016-08-03 |
法国国家健康和医学研究所 |
基于鞭毛蛋白的新型免疫佐剂化合物及其用途
|
ES2545607T3
(es)
*
|
2008-07-08 |
2015-09-14 |
Medicago Inc. |
Antígenos de la gripe recombinantes solubles
|
WO2010036948A2
(en)
|
2008-09-26 |
2010-04-01 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Dna prime/inactivated vaccine boost immunization to influenza virus
|
WO2010117786A1
(en)
|
2009-03-30 |
2010-10-14 |
Mount Sinai School Of Medicine Of New York University |
Influenza virus vaccines and uses thereof
|
NZ596032A
(en)
|
2009-05-11 |
2013-09-27 |
Crucell Holland Bv |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
AU2010254136B2
(en)
|
2009-05-26 |
2016-09-29 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
DK2445928T3
(en)
*
|
2009-06-24 |
2018-05-28 |
Medicago Inc |
CHEMICAL INFLUENZA VIRUS-LIKE PARTICLES INCLUDING HEMAGGLUTIN
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
US20120219584A1
(en)
|
2009-10-05 |
2012-08-30 |
The United States Of America As Represented By The Secretary, Department Of Health |
Protection against pandemic and seasonal strains of influenza
|
JP2013060367A
(ja)
*
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
EP2536425B1
(en)
|
2010-02-18 |
2019-06-19 |
Icahn School of Medicine at Mount Sinai |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
CN102791734B
(zh)
|
2010-03-08 |
2014-10-15 |
赛特瑞恩股份有限公司 |
源自人b细胞且具有抗甲型流感病毒的中和活性的人单克隆抗体
|
AU2011235220B2
(en)
|
2010-03-30 |
2016-03-10 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
EP3450454A1
(en)
|
2010-07-22 |
2019-03-06 |
John W. Schrader |
Cross-protective protection against influenza viral infection
|
US10131695B2
(en)
|
2011-09-20 |
2018-11-20 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
CA2857087C
(en)
|
2011-11-28 |
2021-05-25 |
Crucell Holland B.V. |
Influenza virus vaccines and uses thereof
|
WO2014090865A1
(en)
|
2012-12-11 |
2014-06-19 |
Vib Vzw |
Anti-influenza antibody
|
JP2016508133A
(ja)
|
2012-12-18 |
2016-03-17 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン及びその使用
|
AU2014204826A1
(en)
|
2013-01-10 |
2015-07-09 |
Seqirus UK Limited |
Influenza virus immunogenic compositions and uses thereof
|
AU2014229255B2
(en)
|
2013-03-13 |
2018-12-13 |
Novartis Ag |
Influenza B virus reassortment
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
AU2014236508A1
(en)
|
2013-03-14 |
2015-09-17 |
Contrafect Corporation |
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
|
CA2898235A1
(en)
|
2013-03-15 |
2014-09-25 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
PL235555B1
(pl)
|
2014-06-24 |
2020-09-07 |
Inst Biotechnologii I Antybiotykow |
Wyizolowany i oczyszczony polipeptyd hemaglutyniny (HA ) wirusa grypy H5N1, kompozycja zawierająca polipeptyd i jej zastosowanie, przeciwciało wiążące się specyficznie z polipeptydem oraz sposób otrzymywania tego polipeptydu
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
WO2016205347A1
(en)
|
2015-06-16 |
2016-12-22 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
EP3463447A4
(en)
|
2016-06-03 |
2020-05-27 |
Icahn School of Medicine at Mount Sinai |
INFLUENZA VIRUSES
|
CA3023143A1
(en)
|
2016-06-15 |
2017-12-21 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|